Industry Research Reports
Part 1
Part 2
Part 3
Part 4
Part 5
Home > Reports > Service & Software > Global Electronic Prescribing Software Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Electronic Prescribing Software Market Outlook, In‑Depth Analysis & Forecast to 2031
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Description
The global Electronic Prescribing Software market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Hospitals and Clinics accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Electronic Prescribing Software leading manufacturers including Surescripts, Henry Schein, Cerner Corporation, HealthFusion (NextGen Healthcare), Allscripts, Athenahealth, Bizmatics, EClinicalWorks, Practice Fusion, Medsphere Systems Corporation, etc., dominate supply; the top five capture approximately % of global revenue, with Surescripts leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Electronic Prescribing Software market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
Report Metric
Details
Report Title
Global Electronic Prescribing Software Market Outlook, In‑Depth Analysis & Forecast to 2031
Market Size Available for Years
2025-2031
Global Electronic Prescribing Software Companies Covered
Surescripts
Henry Schein
Cerner Corporation
HealthFusion (NextGen Healthcare)
Allscripts
Athenahealth
Bizmatics
EClinicalWorks
Practice Fusion
Medsphere Systems Corporation
KAREO
DrChrono
RXNT
NextGen
InSync Healthcare Solutions
Global Electronic Prescribing Software Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Electronic Prescribing Software Market, Segment by Type
Stand-Alone Systems
Integrated Systems
Global Electronic Prescribing Software Market, Segment by Application
Hospitals and Clinics
Pharmacy
Others
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Defines the Electronic Prescribing Software study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; top-tier players 2024 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Table of Contents
1 Study Coverage
1.1 Introduction to Electronic Prescribing Software: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Electronic Prescribing Software Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Stand-Alone Systems
1.2.3 Integrated Systems
1.3 Market Segmentation by Application
1.3.1 Global Electronic Prescribing Software Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals and Clinics
1.3.3 Pharmacy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Electronic Prescribing Software Revenue Estimates and Forecasts 2020-2031
2.2 Global Electronic Prescribing Software Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Electronic Prescribing Software Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Electronic Prescribing Software Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Stand-Alone Systems Market Size by Players
3.3.2 Integrated Systems Market Size by Players
3.4 Global Electronic Prescribing Software Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Electronic Prescribing Software Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Electronic Prescribing Software Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Electronic Prescribing Software Market Size by Type (2020-2031)
6.4 North America Electronic Prescribing Software Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Electronic Prescribing Software Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Electronic Prescribing Software Market Size by Type (2020-2031)
7.4 Europe Electronic Prescribing Software Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Electronic Prescribing Software Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Electronic Prescribing Software Market Size by Type (2020-2031)
8.4 Asia-Pacific Electronic Prescribing Software Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Electronic Prescribing Software Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Electronic Prescribing Software Market Size by Type (2020-2031)
9.4 Central and South America Electronic Prescribing Software Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Electronic Prescribing Software Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Electronic Prescribing Software Market Size by Type (2020-2031)
10.4 Middle East and Africa Electronic Prescribing Software Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Electronic Prescribing Software Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Surescripts
11.1.1 Surescripts Corporation Information
11.1.2 Surescripts Business Overview
11.1.3 Surescripts Electronic Prescribing Software Product Features and Attributes
11.1.4 Surescripts Electronic Prescribing Software Revenue and Gross Margin (2020-2025)
11.1.5 Surescripts Electronic Prescribing Software Revenue by Product in 2024
11.1.6 Surescripts Electronic Prescribing Software Revenue by Application in 2024
11.1.7 Surescripts Electronic Prescribing Software Revenue by Geographic Area in 2024
11.1.8 Surescripts Electronic Prescribing Software SWOT Analysis
11.1.9 Surescripts Recent Developments
11.2 Henry Schein
11.2.1 Henry Schein Corporation Information
11.2.2 Henry Schein Business Overview
11.2.3 Henry Schein Electronic Prescribing Software Product Features and Attributes
11.2.4 Henry Schein Electronic Prescribing Software Revenue and Gross Margin (2020-2025)
11.2.5 Henry Schein Electronic Prescribing Software Revenue by Product in 2024
11.2.6 Henry Schein Electronic Prescribing Software Revenue by Application in 2024
11.2.7 Henry Schein Electronic Prescribing Software Revenue by Geographic Area in 2024
11.2.8 Henry Schein Electronic Prescribing Software SWOT Analysis
11.2.9 Henry Schein Recent Developments
11.3 Cerner Corporation
11.3.1 Cerner Corporation Corporation Information
11.3.2 Cerner Corporation Business Overview
11.3.3 Cerner Corporation Electronic Prescribing Software Product Features and Attributes
11.3.4 Cerner Corporation Electronic Prescribing Software Revenue and Gross Margin (2020-2025)
11.3.5 Cerner Corporation Electronic Prescribing Software Revenue by Product in 2024
11.3.6 Cerner Corporation Electronic Prescribing Software Revenue by Application in 2024
11.3.7 Cerner Corporation Electronic Prescribing Software Revenue by Geographic Area in 2024
11.3.8 Cerner Corporation Electronic Prescribing Software SWOT Analysis
11.3.9 Cerner Corporation Recent Developments
11.4 HealthFusion (NextGen Healthcare)
11.4.1 HealthFusion (NextGen Healthcare) Corporation Information
11.4.2 HealthFusion (NextGen Healthcare) Business Overview
11.4.3 HealthFusion (NextGen Healthcare) Electronic Prescribing Software Product Features and Attributes
11.4.4 HealthFusion (NextGen Healthcare) Electronic Prescribing Software Revenue and Gross Margin (2020-2025)
11.4.5 HealthFusion (NextGen Healthcare) Electronic Prescribing Software Revenue by Product in 2024
11.4.6 HealthFusion (NextGen Healthcare) Electronic Prescribing Software Revenue by Application in 2024
11.4.7 HealthFusion (NextGen Healthcare) Electronic Prescribing Software Revenue by Geographic Area in 2024
11.4.8 HealthFusion (NextGen Healthcare) Electronic Prescribing Software SWOT Analysis
11.4.9 HealthFusion (NextGen Healthcare) Recent Developments
11.5 Allscripts
11.5.1 Allscripts Corporation Information
11.5.2 Allscripts Business Overview
11.5.3 Allscripts Electronic Prescribing Software Product Features and Attributes
11.5.4 Allscripts Electronic Prescribing Software Revenue and Gross Margin (2020-2025)
11.5.5 Allscripts Electronic Prescribing Software Revenue by Product in 2024
11.5.6 Allscripts Electronic Prescribing Software Revenue by Application in 2024
11.5.7 Allscripts Electronic Prescribing Software Revenue by Geographic Area in 2024
11.5.8 Allscripts Electronic Prescribing Software SWOT Analysis
11.5.9 Allscripts Recent Developments
11.6 Athenahealth
11.6.1 Athenahealth Corporation Information
11.6.2 Athenahealth Business Overview
11.6.3 Athenahealth Electronic Prescribing Software Product Features and Attributes
11.6.4 Athenahealth Electronic Prescribing Software Revenue and Gross Margin (2020-2025)
11.6.5 Athenahealth Recent Developments
11.7 Bizmatics
11.7.1 Bizmatics Corporation Information
11.7.2 Bizmatics Business Overview
11.7.3 Bizmatics Electronic Prescribing Software Product Features and Attributes
11.7.4 Bizmatics Electronic Prescribing Software Revenue and Gross Margin (2020-2025)
11.7.5 Bizmatics Recent Developments
11.8 EClinicalWorks
11.8.1 EClinicalWorks Corporation Information
11.8.2 EClinicalWorks Business Overview
11.8.3 EClinicalWorks Electronic Prescribing Software Product Features and Attributes
11.8.4 EClinicalWorks Electronic Prescribing Software Revenue and Gross Margin (2020-2025)
11.8.5 EClinicalWorks Recent Developments
11.9 Practice Fusion
11.9.1 Practice Fusion Corporation Information
11.9.2 Practice Fusion Business Overview
11.9.3 Practice Fusion Electronic Prescribing Software Product Features and Attributes
11.9.4 Practice Fusion Electronic Prescribing Software Revenue and Gross Margin (2020-2025)
11.9.5 Practice Fusion Recent Developments
11.10 Medsphere Systems Corporation
11.10.1 Medsphere Systems Corporation Corporation Information
11.10.2 Medsphere Systems Corporation Business Overview
11.10.3 Medsphere Systems Corporation Electronic Prescribing Software Product Features and Attributes
11.10.4 Medsphere Systems Corporation Electronic Prescribing Software Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 KAREO
11.11.1 KAREO Corporation Information
11.11.2 KAREO Business Overview
11.11.3 KAREO Electronic Prescribing Software Product Features and Attributes
11.11.4 KAREO Electronic Prescribing Software Revenue and Gross Margin (2020-2025)
11.11.5 KAREO Recent Developments
11.12 DrChrono
11.12.1 DrChrono Corporation Information
11.12.2 DrChrono Business Overview
11.12.3 DrChrono Electronic Prescribing Software Product Features and Attributes
11.12.4 DrChrono Electronic Prescribing Software Revenue and Gross Margin (2020-2025)
11.12.5 DrChrono Recent Developments
11.13 RXNT
11.13.1 RXNT Corporation Information
11.13.2 RXNT Business Overview
11.13.3 RXNT Electronic Prescribing Software Product Features and Attributes
11.13.4 RXNT Electronic Prescribing Software Revenue and Gross Margin (2020-2025)
11.13.5 RXNT Recent Developments
11.14 NextGen
11.14.1 NextGen Corporation Information
11.14.2 NextGen Business Overview
11.14.3 NextGen Electronic Prescribing Software Product Features and Attributes
11.14.4 NextGen Electronic Prescribing Software Revenue and Gross Margin (2020-2025)
11.14.5 NextGen Recent Developments
11.15 InSync Healthcare Solutions
11.15.1 InSync Healthcare Solutions Corporation Information
11.15.2 InSync Healthcare Solutions Business Overview
11.15.3 InSync Healthcare Solutions Electronic Prescribing Software Product Features and Attributes
11.15.4 InSync Healthcare Solutions Electronic Prescribing Software Revenue and Gross Margin (2020-2025)
11.15.5 InSync Healthcare Solutions Recent Developments
12 Electronic Prescribing SoftwareIndustry Chain Analysis
12.1 Electronic Prescribing Software Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Electronic Prescribing Software Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Electronic Prescribing Software Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
Table of Figures
List of Tables
Table 1. Global Electronic Prescribing Software Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Electronic Prescribing Software Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Electronic Prescribing Software Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Electronic Prescribing Software Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Electronic Prescribing Software Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Electronic Prescribing Software Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Electronic Prescribing Software Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Electronic Prescribing Software by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Electronic Prescribing Software as of 2024)
Table 11. Global Electronic Prescribing Software Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Electronic Prescribing Software Companies Headquarters
Table 13. Global Electronic Prescribing Software Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Electronic Prescribing Software Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Electronic Prescribing Software Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Electronic Prescribing Software Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Electronic Prescribing Software Revenue by Application (2026-2031) & (US$ Million)
Table 21. Electronic Prescribing Software High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Electronic Prescribing Software Growth Accelerators and Market Barriers
Table 25. North America Electronic Prescribing Software Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Electronic Prescribing Software Growth Accelerators and Market Barriers
Table 27. Europe Electronic Prescribing Software Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Electronic Prescribing Software Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Electronic Prescribing Software Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Electronic Prescribing Software Investment Opportunities and Key Challenges
Table 31. Central and South America Electronic Prescribing Software Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Electronic Prescribing Software Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Electronic Prescribing Software Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Surescripts Corporation Information
Table 35. Surescripts Description and Major Businesses
Table 36. Surescripts Product Features and Attributes
Table 37. Surescripts Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Surescripts Revenue Proportion by Product in 2024
Table 39. Surescripts Revenue Proportion by Application in 2024
Table 40. Surescripts Revenue Proportion by Geographic Area in 2024
Table 41. Surescripts Electronic Prescribing Software SWOT Analysis
Table 42. Surescripts Recent Developments
Table 43. Henry Schein Corporation Information
Table 44. Henry Schein Description and Major Businesses
Table 45. Henry Schein Product Features and Attributes
Table 46. Henry Schein Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Henry Schein Revenue Proportion by Product in 2024
Table 48. Henry Schein Revenue Proportion by Application in 2024
Table 49. Henry Schein Revenue Proportion by Geographic Area in 2024
Table 50. Henry Schein Electronic Prescribing Software SWOT Analysis
Table 51. Henry Schein Recent Developments
Table 52. Cerner Corporation Corporation Information
Table 53. Cerner Corporation Description and Major Businesses
Table 54. Cerner Corporation Product Features and Attributes
Table 55. Cerner Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Cerner Corporation Revenue Proportion by Product in 2024
Table 57. Cerner Corporation Revenue Proportion by Application in 2024
Table 58. Cerner Corporation Revenue Proportion by Geographic Area in 2024
Table 59. Cerner Corporation Electronic Prescribing Software SWOT Analysis
Table 60. Cerner Corporation Recent Developments
Table 61. HealthFusion (NextGen Healthcare) Corporation Information
Table 62. HealthFusion (NextGen Healthcare) Description and Major Businesses
Table 63. HealthFusion (NextGen Healthcare) Product Features and Attributes
Table 64. HealthFusion (NextGen Healthcare) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. HealthFusion (NextGen Healthcare) Revenue Proportion by Product in 2024
Table 66. HealthFusion (NextGen Healthcare) Revenue Proportion by Application in 2024
Table 67. HealthFusion (NextGen Healthcare) Revenue Proportion by Geographic Area in 2024
Table 68. HealthFusion (NextGen Healthcare) Electronic Prescribing Software SWOT Analysis
Table 69. HealthFusion (NextGen Healthcare) Recent Developments
Table 70. Allscripts Corporation Information
Table 71. Allscripts Description and Major Businesses
Table 72. Allscripts Product Features and Attributes
Table 73. Allscripts Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Allscripts Revenue Proportion by Product in 2024
Table 75. Allscripts Revenue Proportion by Application in 2024
Table 76. Allscripts Revenue Proportion by Geographic Area in 2024
Table 77. Allscripts Electronic Prescribing Software SWOT Analysis
Table 78. Allscripts Recent Developments
Table 79. Athenahealth Corporation Information
Table 80. Athenahealth Description and Major Businesses
Table 81. Athenahealth Product Features and Attributes
Table 82. Athenahealth Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Athenahealth Recent Developments
Table 84. Bizmatics Corporation Information
Table 85. Bizmatics Description and Major Businesses
Table 86. Bizmatics Product Features and Attributes
Table 87. Bizmatics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Bizmatics Recent Developments
Table 89. EClinicalWorks Corporation Information
Table 90. EClinicalWorks Description and Major Businesses
Table 91. EClinicalWorks Product Features and Attributes
Table 92. EClinicalWorks Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. EClinicalWorks Recent Developments
Table 94. Practice Fusion Corporation Information
Table 95. Practice Fusion Description and Major Businesses
Table 96. Practice Fusion Product Features and Attributes
Table 97. Practice Fusion Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Practice Fusion Recent Developments
Table 99. Medsphere Systems Corporation Corporation Information
Table 100. Medsphere Systems Corporation Description and Major Businesses
Table 101. Medsphere Systems Corporation Product Features and Attributes
Table 102. Medsphere Systems Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Medsphere Systems Corporation Recent Developments
Table 104. KAREO Corporation Information
Table 105. KAREO Description and Major Businesses
Table 106. KAREO Product Features and Attributes
Table 107. KAREO Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. KAREO Recent Developments
Table 109. DrChrono Corporation Information
Table 110. DrChrono Description and Major Businesses
Table 111. DrChrono Product Features and Attributes
Table 112. DrChrono Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. DrChrono Recent Developments
Table 114. RXNT Corporation Information
Table 115. RXNT Description and Major Businesses
Table 116. RXNT Product Features and Attributes
Table 117. RXNT Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. RXNT Recent Developments
Table 119. NextGen Corporation Information
Table 120. NextGen Description and Major Businesses
Table 121. NextGen Product Features and Attributes
Table 122. NextGen Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. NextGen Recent Developments
Table 124. InSync Healthcare Solutions Corporation Information
Table 125. InSync Healthcare Solutions Description and Major Businesses
Table 126. InSync Healthcare Solutions Product Features and Attributes
Table 127. InSync Healthcare Solutions Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. InSync Healthcare Solutions Recent Developments
Table 129. Raw Materials Key Suppliers
Table 130. Distributors List
Table 131. Market Trends and Market Evolution
Table 132. Market Drivers and Opportunities
Table 133. Market Challenges, Risks, and Restraints
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Electronic Prescribing Software Product Picture
Figure 2. Global Electronic Prescribing Software Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Stand-Alone Systems Product Picture
Figure 4. Integrated Systems Product Picture
Figure 5. Global Electronic Prescribing Software Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospitals and Clinics
Figure 7. Pharmacy
Figure 8. Others
Figure 9. Electronic Prescribing Software Report Years Considered
Figure 10. Global Electronic Prescribing Software Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Electronic Prescribing Software Revenue (2020-2031) & (US$ Million)
Figure 12. Global Electronic Prescribing Software Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Electronic Prescribing Software Revenue Market Share by Region (2020-2031)
Figure 14. Global Electronic Prescribing Software Revenue Market Share Ranking (2024)
Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 16. Stand-Alone Systems Revenue Market Share by Player in 2024
Figure 17. Integrated Systems Revenue Market Share by Player in 2024
Figure 18. Global Electronic Prescribing Software Revenue Market Share by Type (2020-2031)
Figure 19. Global Electronic Prescribing Software Revenue Market Share by Application (2020-2031)
Figure 20. North America Electronic Prescribing Software Revenue YoY (2020-2031) & (US$ Million)
Figure 21. North America Top 5 Players Electronic Prescribing Software Revenue (US$ Million) in 2024
Figure 22. North America Electronic Prescribing Software Revenue (US$ Million) by Type (2020 - 2031)
Figure 23. North America Electronic Prescribing Software Revenue (US$ Million) by Application (2020-2031)
Figure 24. US Electronic Prescribing Software Revenue (2020-2031) & (US$ Million)
Figure 25. Canada Electronic Prescribing Software Revenue (2020-2031) & (US$ Million)
Figure 26. Mexico Electronic Prescribing Software Revenue (2020-2031) & (US$ Million)
Figure 27. Europe Electronic Prescribing Software Revenue YoY (2020-2031) & (US$ Million)
Figure 28. Europe Top 5 Players Electronic Prescribing Software Revenue (US$ Million) in 2024
Figure 29. Europe Electronic Prescribing Software Revenue (US$ Million) by Type (2020-2031)
Figure 30. Europe Electronic Prescribing Software Revenue (US$ Million) by Application (2020-2031)
Figure 31. Germany Electronic Prescribing Software Revenue (2020-2031) & (US$ Million)
Figure 32. France Electronic Prescribing Software Revenue (2020-2031) & (US$ Million)
Figure 33. U.K. Electronic Prescribing Software Revenue (2020-2031) & (US$ Million)
Figure 34. Italy Electronic Prescribing Software Revenue (2020-2031) & (US$ Million)
Figure 35. Russia Electronic Prescribing Software Revenue (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Electronic Prescribing Software Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Top 8 Players Electronic Prescribing Software Revenue (US$ Million) in 2024
Figure 38. Asia-Pacific Electronic Prescribing Software Revenue (US$ Million) by Type (2020-2031)
Figure 39. Asia-Pacific Electronic Prescribing Software Revenue (US$ Million) by Application (2020-2031)
Figure 40. Indonesia Electronic Prescribing Software Revenue (2020-2031) & (US$ Million)
Figure 41. Japan Electronic Prescribing Software Revenue (2020-2031) & (US$ Million)
Figure 42. South Korea Electronic Prescribing Software Revenue (2020-2031) & (US$ Million)
Figure 43. Australia Electronic Prescribing Software Revenue (2020-2031) & (US$ Million)
Figure 44. India Electronic Prescribing Software Revenue (2020-2031) & (US$ Million)
Figure 45. Indonesia Electronic Prescribing Software Revenue (2020-2031) & (US$ Million)
Figure 46. Vietnam Electronic Prescribing Software Revenue (2020-2031) & (US$ Million)
Figure 47. Malaysia Electronic Prescribing Software Revenue (2020-2031) & (US$ Million)
Figure 48. Philippines Electronic Prescribing Software Revenue (2020-2031) & (US$ Million)
Figure 49. Singapore Electronic Prescribing Software Revenue (2020-2031) & (US$ Million)
Figure 50. Central and South America Electronic Prescribing Software Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Central and South America Top 5 Players Electronic Prescribing Software Revenue (US$ Million) in 2024
Figure 52. Central and South America Electronic Prescribing Software Revenue (US$ Million) by Type (2020-2031)
Figure 53. Central and South America Electronic Prescribing Software Revenue (US$ Million) by Application (2020-2031)
Figure 54. Brazil Electronic Prescribing Software Revenue (2020-2025) & (US$ Million)
Figure 55. Argentina Electronic Prescribing Software Revenue (2020-2025) & (US$ Million)
Figure 56. Middle East and Africa Electronic Prescribing Software Revenue YoY (2020-2031) & (US$ Million)
Figure 57. Middle East and Africa Top 5 Players Electronic Prescribing Software Revenue (US$ Million) in 2024
Figure 58. South America Electronic Prescribing Software Revenue (US$ Million) by Type (2020-2031)
Figure 59. Middle East and Africa Electronic Prescribing Software Revenue (US$ Million) by Application (2020-2031)
Figure 60. GCC Countries Electronic Prescribing Software Revenue (2020-2025) & (US$ Million)
Figure 61. Israel Electronic Prescribing Software Revenue (2020-2025) & (US$ Million)
Figure 62. Egypt Electronic Prescribing Software Revenue (2020-2025) & (US$ Million)
Figure 63. South Africa Electronic Prescribing Software Revenue (2020-2025) & (US$ Million)
Figure 64. Electronic Prescribing Software Industry Chain Mapping
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives InterviewedDescription
The global Electronic Prescribing Software market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Hospitals and Clinics accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Electronic Prescribing Software leading manufacturers including Surescripts, Henry Schein, Cerner Corporation, HealthFusion (NextGen Healthcare), Allscripts, Athenahealth, Bizmatics, EClinicalWorks, Practice Fusion, Medsphere Systems Corporation, etc., dominate supply; the top five capture approximately % of global revenue, with Surescripts leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Electronic Prescribing Software market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
Chapter Outline
Chapter 1: Defines the Electronic Prescribing Software study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; top-tier players 2024 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Related Reports
Global Electronic Prescribing Software Market Research Report 2024
The global Electronic Prescribing Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-12
Pages: 96
USD 2900.00
(Single User License)
Global Electronic Prescribing Software Market Insights, Forecast to 2030
Market Analysis and Insights: Global Electronic Prescribing Software Market
Published: 2024-04-12
Pages: 116
USD 4900.00
(Single User License)
Electronic Prescribing Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Electronic Prescribing Software was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-08
Pages: 128
USD 3950.00
(Single User License)
Global Electronic Prescribing Software Market Research Report 2025
The global market for Electronic Prescribing Software was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-07
Pages: 88
USD 2900.00
(Single User License)
Electronic Prescribing Software- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Electronic Prescribing Software was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 104
USD 3950.00
(Single User License)
Global Electronic Prescribing Software Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Electronic Prescribing Software market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-16
Pages: 93
USD 4250.00
(Single User License)
Global Electronic Prescribing Software Market Research Report 2024
The global Electronic Prescribing Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-12
Pages: 96
USD 2900.00 ()Global Electronic Prescribing Software Market Insights, Forecast to 2030
Market Analysis and Insights: Global Electronic Prescribing Software Market
Published: 2024-04-12
Pages: 116
USD 4900.00 ()Electronic Prescribing Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Electronic Prescribing Software was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-08
Pages: 128
USD 3950.00 ()Global Electronic Prescribing Software Market Research Report 2025
The global market for Electronic Prescribing Software was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-07
Pages: 88
USD 2900.00 ()Electronic Prescribing Software- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Electronic Prescribing Software was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 104
USD 3950.00 ()Global Electronic Prescribing Software Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Electronic Prescribing Software market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-16
Pages: 93
USD 4250.00 ()
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
Have a question?
General Email:
WHAT QYRESEARCH OFFER?
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
INTEREST IN THIS REPORT?
Get A Free Sample >>
WHY QYR?
Fastest report delivery service
More than 19 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database